Streetbeat News

Price Targets

DY

B. Riley Securities has downgraded Dycom Industries (NYSE:DY) from Buy to Neutral and lowered the price target from $134 to $111.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:56 am

ZWS

Baird analyst Michael Halloran maintains a Neutral rating on Zurn Elkay Water (NYSE:ZWS) and raises the price target from $23 to $30.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 9:55 am

RTX

Morgan Stanley analyst Kristine Liwag has downgraded RTX (NYSE:RTX) from Overweight to Equal-Weight and lowered the price target from $110 to $95.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:53 am

NTAP

Morgan Stanley analyst Meta Marshall has upgraded NetApp (NASDAQ:NTAP) from Underweight to Equal-Weight and raised the price target from $60 to $74.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:52 am

BMTX

Chardan Capital analyst Brian Dobson has maintained a 'Buy' rating on BM Technologies (AMEX:BMTX), but lowered the price target from $13 to $8.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:50 am

ATRC

Needham analyst Mike Matson maintains a 'Buy' rating on AtriCure (NASDAQ:ATRC) and raises the price target from $60 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:49 am

MMSI

Needham analyst Mike Matson has reiterated a 'Buy' rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $96.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:48 am

PHM

BTIG analyst Carl Reichardt maintains a Buy rating on PulteGroup (NYSE:PHM) and raises the price target from $83 to $100.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 9:47 am

SNDX

Barclays analyst Peter Lawson maintains an Overweight rating on Syndax Pharmaceuticals (NASDAQ:SNDX) and raises the price target from $31 to $34.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 26, 2023 | 9:44 am

VFC

Telsey Advisory Group has reiterated its 'Outperform' rating on VF Corporation (NYSE:VFC) and maintained its price target of $27.

Portfolio Pulse from richadhand@benzinga.com

July 26, 2023 | 9:20 am